Wave Life Sciences Ltd. (WVE) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Wave Life Sciences Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.051 -- 00:00:05.516 Hello and welcome to Wave Life Sciences' second quarter 2026 earnings call. 00:00:05.516 -- 00:00:09.799 We ask that you please hold all questions until the completion of the formal remarks. 00:00:09.799 -- 00:00:13.723 At which time you'll be given instructions for the question and answer session. 00:00:13.723 -- 00:00:17.346 Also, as a reminder, this conference is being recorded today. 00:00:17.346 -- 00:00:20.889 I will now turn the call over to Kate Rausch, Vice President of Corporate Affairs and 00:00:20.889 -- 00:00:23.269 Investor Relations. 00:00:23.443 -- 00:00:26.044 Thank you, operator, and good morning to everyone on the call. 00:00:26.044 -- 00:00:30.004 Earlier this morning, we issued a press release outlining our second quarter 2026 earnings 00:00:30.004 -- 00:00:33.405 update. Joining me today with prepared remarks are Dr. 00:00:33.405 -- 00:00:36.505 Paul Bolno, President and Chief Executive Officer, Dr. 00:00:36.505 -- 00:00:39.066 Erik Ingelsson, Chief Scientific Officer, Dr. 00:00:39.066 -- 00:00:43.907 Chris Wright, Chief Medical Officer, and Kyle Moran, Chief Financial Officer. 00:00:43.907 -- 00:00:47.608 The press release issued this morning is available on the investor section of our website, 00:00:47.608 -- 00:00:49.608 www.wavelifesciences.com. 00:00:50.473 -- 00:00:53.715 Before we begin, I would like to remind you that discussions during this conference call 00:00:53.715 -- 00:00:57.197 will include forward-looking statements. These statements are subject to several risks 00:00:57.197 -- 00:01:00.719 and uncertainties that could cause our actual results to differ materially from those 00:01:00.719 -- 00:01:02.801 described in these forward-looking statements. 00:01:02.801 -- 00:01:06.283 The factors tha...